SPOP and Familial prostate cancer: SPOP mutants associated with prostate cancer fail to interact with and ubiquitinate their substrates, leading to the accumulation of oncogenic substrate proteins such as androgen receptor (AR), BRD2, and BRD4 [22,23,24,25].